PI 3-kinase p85α Activators encompass a range of chemical compounds that enhance the protein's activity through various signaling pathways. Wortmannin, LY294002, GDC-0941, ZSTK474, Apigenin, and Pictilisib, all function as inhibitors of PI 3-kinase. The inhibition of PI 3-kinase by these compounds leads to an indirect enhancement of PI 3-kinase p85α's role in the PI3K/Akt signaling pathway. This enhancement is critical in maintaining a balanced activity level of the protein, ensuring its regulatory function in controlling key cellular processes such as growth, survival, and metabolism. For instance, LY294002 and Wortmannin, by specifically targeting PI 3-kinase, modulate the PI3K/Akt pathway, thereby maintaining the regulatory role of PI 3-kinase p85α. Similarly, GDC-0941 and Pictilisib, through their selective inhibition of PI 3-kinase, indirectly enhance PI 3-kinase p85α's role in regulating cellular processes. Apigenin, by inhibiting PI 3-kinase, also contributes to the enhancement of PI 3-kinase p85α's regulatory functions in response to external growth signals.
The activity of PI 3-kinase p85α is further influenced by growth factors and other signaling molecules like PDGF, Insulin, IGF-1, EGF, and the pharmacological agents U73122 and SH-4-54. PDGF, Insulin, and IGF-1 activate their respective receptors, which in turn initiate a cascade leading to the activation of PI 3-kinase and an indirect enhancement of PI 3-kinase p85α's function in signal transduction related to cell proliferation, migration, and metabolic regulation. EGF, through its interaction with the EGFR, also contributes to the activation of PI 3-kinase, thereby enhancing the role of PI 3-kinase p85α in cellular proliferation and survival pathways. Additionally, U73122, by inhibiting phospholipase C, and SH-4-54, through direct inhibition of Akt, induce a compensatory increase in PI 3-kinase activity. This increase indirectly enhances the functional role of PI 3-kinase p85α in the PI3K/Akt pathway, highlighting its pivotal role in regulating key cellular processes. Collectively, these activators, through their targeted effects on cellular signaling, facilitate the enhancement of PI 3-kinase p85α mediated functions without the need for upregulating its expression or direct activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of PI 3-kinase. By inhibiting PI 3-kinase activity, wortmannin indirectly enhances the activity of PI 3-kinase p85α by preventing its overactivation and preserving its regulatory role in the PI3K/Akt signaling pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of PI 3-kinase. It modulates the PI3K/Akt pathway by inhibiting overactive PI 3-kinase, thus enhancing the regulatory function of PI 3-kinase p85α in controlling cell growth and survival. | ||||||
Alendronate acid | 66376-36-1 | sc-337520 | 5 g | $135.00 | 2 | |
Platelet-Derived Growth Factor (PDGF) binds to its receptor, leading to the activation of PI 3-kinase. This activation indirectly increases PI 3-kinase p85α's role in mediating signal transduction for cell proliferation and migration. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the insulin receptor, triggering a cascade that includes the activation of PI 3-kinase. This enhances the role of PI 3-kinase p85α in glucose metabolism and cellular growth pathways. | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $188.00 $199.00 | 2 | |
GDC-0941 is a selective inhibitor of PI 3-kinase. By modulating the PI3K pathway, it indirectly enhances the activity of PI 3-kinase p85α, maintaining its role in regulating key cellular processes like growth and survival. | ||||||
ZSTK 474 | 475110-96-4 | sc-475495 | 5 mg | $75.00 | ||
ZSTK474 inhibits PI 3-kinase, indirectly enhancing the role of PI 3-kinase p85α in the PI3K/Akt pathway, particularly in regulating cell growth and survival. | ||||||
Apigenin | 520-36-5 | sc-3529 sc-3529A sc-3529B sc-3529C sc-3529D sc-3529E sc-3529F | 5 mg 100 mg 1 g 5 g 25 g 100 g 1 kg | $33.00 $214.00 $734.00 $1151.00 $2348.00 $3127.00 $5208.00 | 22 | |
Apigenin inhibits PI 3-kinase indirectly, leading to an enhancement of PI 3-kinase p85α's regulatory role in cell signaling pathways, especially in cellular responses to external growth signals. | ||||||